Silexion Therapeutics Holds Reconvened Shareholder Meeting After Quorum Shortfall
Bitget2026/10/26 20:09- Silexion Therapeutics shareholders approved a 500,000,000-ordinary-share authorized capital increase at the extraordinary meeting reconvened on October 26, 2026.
- Originally held on October 19, 2026, the meeting also authorized a reverse share split ranging from 1-for-15 to 1-for-25.
- The capital amendment became effective October 26, 2026, increasing authorized ordinary shares from 15,900,000 to 515,900,000.
- The board selected a 1-for-24 ratio for the authorized reverse split, covering issued and outstanding ordinary shares and authorized but unissued ordinary shares.
- The reverse split would increase ordinary shares’ par value from US$0.135 to US$3.24.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ripple's Dubai Event Presence Gets High-Profile Boost From Emirates Chairman
Signal of a rebound? Goldman Sachs US stock panic index reaches "extreme levels"
Goldman Sachs Volatility Panic Index surged to 9.57, approaching its maximum value, with the largest single-day increase ranking third in history, and the combined two-day volatility setting a new record. Historical data shows that after this index has exceeded the 9.5 threshold 15 times, the S&P 500 has seen an average three-month gain of 4.6% with a success rate of 80%. However, Goldman Sachs traders warn that forced liquidations have not yet fully cleared, and the market is still searching for a bottom, but opportunities on the other side are becoming increasingly difficult to ignore.
SpaceX (SPCX.US) undergoes board changes: Google executive departs, Tesla merger evaluation underway.
SpaceX (SPCX.US) announced on Friday that Don Harrison has resigned from the company's board of directors.
Crypto prices
More
